Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer’s disease
In recent years, the Alzheimer’s disease (AD) epidemic has become one of the largest global healthcare crises. Besides, the available systemic therapies for AD are still inadequate. Due to the insufficient therapeutic options, new treatment strategies are urgently needed to achieve a satisfactory th...
Main Authors: | Rui Xie, Feng Chen, Yixuan Ma, Wen Hu, Qiang Zheng, Jinguo Cao, Yi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1249632/full |
Similar Items
-
Antimicrobial and Cytotoxic Assessment of Marine Cyanobacteria - Synechocystis and Synechococcus
by: Vitor M. Vasconcelos, et al.
Published: (2008-01-01) -
Editorial: Physiology and molecular biology of aquatic cyanobacteria
by: George S Bullerjahn, et al.
Published: (2014-07-01) -
Determination of Volatile Organic Compounds and Antibacterial Activity of the Amazonian Cyanobacterium <i>Synechococcus</i> sp. Strain GFB01
by: Samuel Cavalcante do Amaral, et al.
Published: (2020-10-01) -
Multiple Photolyases Protect the Marine Cyanobacterium Synechococcus from Ultraviolet Radiation
by: Allissa M. Haney, et al.
Published: (2022-08-01) -
Quantitative analysis of the effects of morphological changes on extracellular electron transfer rates in cyanobacteria
by: Tonny I. Okedi, et al.
Published: (2020-08-01)